Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), will introduce three new oncology biosimilars, further ...

Accept rupee depreciation as structural, not temporary ...

Despite limited uptake, weight-loss drugs have topped drug sales in India by value — marking a shift in how people perceive ...

This video shows a $4 Million Lamborghini Sian driving through the busy streets of Central London. The hybrid supercar ...

Heceta Head Lighthouse stands boldly on Oregon’s rugged coastline. It’s a timeless guide for ships — and now, for travelers.

Rajesh Bhosale of Angel One recommends Engineers India, NMDC and Titan Company, citing bullish technical breakouts, strong ...

Will markets bounce back or continue to correct? Which sectors will lead? Can gold sustain its stellar run? Will interest ...

As Dalal Street heads into the next session, Zee Business analysts Priyanka Anand and Pooja Tripathi have lined up fresh ...

Viatris is letting go of the equity stake it’s held in Biocon’s biosimilar subsidiary Biocon Biologics for $815 million, allowing Biocon to fully integrate its subsidiary. The Viatris stake is one of ...

Biocon has announced that it is to fully integrate Biocon Biologics Limited Biocon share price is in focus today after the company announced a major restructuring move involving its biologics business ...

Viatris (VTRS) on Saturday said that it has entered into definitive agreements with Biocon for the sale of Viatris' equity stake in Biocon Biologics Limited. Under the definitive agreements, Biocon ...

I write about Asia's richest, fast-growing businesses, and startups. Biocon—controlled by Indian pharmaceutical billionaire Kiran Mazumdar-Shaw—is buying the rest of privately held subsidiary Biocon ...